User Guide

13-25
AsyncOS 9.1.2 for Cisco Email Security Appliances User Guide
Chapter 13 Anti-Spam
Testing Anti-Spam
Testing Anti-Spam
Related Topics
Sending an Email to the Appliance to Test Cisco Anti-Spam, page 13-25
Ways Not to Test Anti-Spam Efficacy, page 13-26
Sending an Email to the Appliance to Test Cisco Anti-Spam
Before You Begin
Understand how to use Telnet with the appliance. See Appendix A, “FTP, SSH, and SCP Access”
Review the example in Testing Anti-Spam Configuration: Example Using SMTP, page 13-25.
Procedure
Step 1 Enable Cisco Anti-Spam on a mail policy.
Step 2 Send a test email that includes the following header to a user in that mail policy:
X-Advertisement: spam
Use SMTP commands with Telnet to send this message to an address to which you have access.
Step 3 Check the mailbox of the test account and confirm that the test message was correctly delivered based
upon the actions you configured for the mail policy.
For example:
Was the subject line altered?
Was your additional custom header added?
Was the message delivered to an alternate address?
Was the message dropped?
To Do This More Information
Test your configuration. Test your configuration using the
X-advertisement: spam header.
For testing purposes, Cisco Anti-Spam
considers any message with an
X-header formatted as
X-Advertisement: spam to be spam.
The test message you send with this header is flagged by
Cisco Anti-Spam, and you can confirm that the actions
you configured for the mail policy (Defining Anti-Spam
Policies, page 13-7) are performed.
Use this header with one of the following:
Use SMTP commands to send a test message with
this header. See Sending an Email to the Appliance
to Test Cisco Anti-Spam, page 13-25.
Use the trace command and include this header. See
Debugging Mail Flow Using Test Messages: Trace,
page 40-1.
Evaluate Anti-Spam
engine efficacy.
Evaluate the product using a live mail
stream directly from the Internet.
For a list of ineffective evaluation approaches that you
should avoid, see Ways Not to Test Anti-Spam Efficacy,
page 13-26.